Uri Geiger - 15 Jul 2024 Form 4 Insider Report for STRATA Skin Sciences, Inc. (SSKN)

Role: Director, 10%+ Owner
Signature: /s/ Uri Geiger
Issuer symbol: SSKN
Transactions as of: 15 Jul 2024
Net transactions value: +$723,999
Form type: 4
Filing time: 17 Jul 2024, 17:08:57 UTC
Previous filing: 11 Jun 2024
Next filing: 09 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SSKN	Common Stock	Purchase	$723,999	+230,573	+19%	$3.14	1,441,835	15 Jul 2024	See footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares are held directly by Accelmed Partners, L.P. The reporting person is the controlling member and managing partner of Accelmed Growth Partners (AGP) Limited, which is the general partner of Accelmed Partners (GP), L.P., which is the general partner of Accelmed Partners, L.P. and as a result he may be deemed to beneficially own the shares of common stock held by Accelmed Partners, L.P. The reporting person is the controlling shareholder and managing partner of Accelmed Growth Partners Management Ltd., which has certain voting and dispositive power over the shares of common stock owned by Accelmed Partners, L.P. pursuant to a management agreement, and as a result the reporting person may be deemed to beneficially own the shares of the common stock held by Accelmed Partners, L.P. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein.

Content

Shares are held directly by Accelmed Partners, L.P. The reporting person is the controlling member and managing partner of Accelmed Growth Partners (AGP) Limited, which is the general partner of Accelmed Partners (GP), L.P., which is the general partner of Accelmed Partners, L.P. and as a result he may be deemed to beneficially own the shares of common stock held by Accelmed Partners, L.P. The reporting person is the controlling shareholder and managing partner of Accelmed Growth Partners Management Ltd., which has certain voting and dispositive power over the shares of common stock owned by Accelmed Partners, L.P. pursuant to a management agreement, and as a result the reporting person may be deemed to beneficially own the shares of the common stock held by Accelmed Partners, L.P. The reporting person disclaims such beneficial ownership except to the extent of his pecuniary interest therein.